Sunshine Biopharma- Warrants (15/02/2027) Common Stock

As of the most recent data (June 2026), SBFMW shows a common stock of $2.4K. That compares with $4.6K in the prior-year period — down 47.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SBFMW's common stock is now $2.4K (was $4.6K) — a 47.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sunshine Biopharma- Warrants (15/02/2027) is outperforming or lagging.

Tracking SBFMW's common stock over time shows whether Sunshine Biopharma- Warrants (15/02/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4K That compares with $4.6K in the prior-year period — down 47.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Sunshine Biopharma- Warrants (15/02/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $2.4K) with ownership activity and broader fundamentals.

Sunshine Biopharma- Warrants (15/02/2027)'s common stock is $2.4K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.